Synapse - Real-life experience with lenalidomide plus anti-CD20 antibodies for the treatment of patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL)

Real-life experience with lenalidomide plus anti-CD20 antibodies for the treatment of patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) Meeting Abstract

Authors:	Cassanello, G.; Rivas-Delgado, A.; Luna De Abia, A.; Corona, M.; Luttwak, E.; Okwali, M.; Isgor, I.; Galera, P.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Ghione, P.; Hamlin, P. A.; Lue, J. K.; Horwitz, S. M.; Intlekofer, A. M.; Johnson, W.; Kumar, A.; Moskowitz, A.; Noy, A.; Owens, C.; Palomba, M. L.; Stuver, R.; Torka, P.; Vardhana, S. A.; Zelenetz, A. D.; Salles, G.; Falchi, L.
Abstract Title:	Real-life experience with lenalidomide plus anti-CD20 antibodies for the treatment of patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL)
Meeting Title:	65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	142
Issue:	Suppl. 1
Meeting Dates:	2023 Dec 9-12
Meeting Location:	San Deigo, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2023-11-02
Start Page:	1686
Language:	English
ACCESSION:	WOS:001159306706157
DOI:	10.1182/blood-2023-187783
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos